(LGND) Ligand Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Ligand Pharmaceuticals | (LGND) share price targets
Complete technical analysis of Ligand Pharmaceuticals (LGND) by charts plus indicators, forecast predictions and share price targets for Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-22 View latest technical analysis
10 day averaged volume of Ligand Pharmaceuticals is 115883
| Date | Daily Closing Price | Open | High | Low | Volume |
| 22 Thu Aug 2024 | 103.62 | 106.25 | 106.25 | 103.21 | 0.576 times |
| 21 Wed Aug 2024 | 106.08 | 105.00 | 106.84 | 102.87 | 1.051 times |
| 20 Tue Aug 2024 | 104.34 | 103.00 | 104.73 | 101.88 | 0.866 times |
| 19 Mon Aug 2024 | 103.05 | 102.00 | 103.05 | 101.11 | 0.348 times |
| 16 Fri Aug 2024 | 102.21 | 103.27 | 104.28 | 102.20 | 0.838 times |
| 15 Thu Aug 2024 | 103.13 | 102.93 | 106.75 | 102.69 | 1.277 times |
| 14 Wed Aug 2024 | 101.02 | 102.62 | 103.88 | 101.00 | 0.825 times |
| 13 Tue Aug 2024 | 103.02 | 100.10 | 103.04 | 99.15 | 1.759 times |
| 12 Mon Aug 2024 | 99.60 | 103.28 | 103.28 | 98.71 | 0.983 times |
| 09 Fri Aug 2024 | 100.15 | 97.33 | 100.76 | 95.28 | 1.136 times |
My analysis of stock is bullish for shortterm, and stock might move up till 106.8 or till 111.9. Use a stoploss of 102.66 and if this stock hits its stoploss, then it can fall down till 98.48
Share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Target | 67.72 |
| Downside Target | 69.51 |
| Downside Target | 77.43 |
| Downside Target | 81.73 |
| Downside Target | 88.52 |
| Downside Target | 98.03 |
| Downside Target | 101.11 |
| Upside Target | 106.75 |
| Upside Target | 106.84 |
| Upside Target | 108.91 |
| Upside Target | 108.98 |
| Upside Target | 112.13 |
Intraday share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Intraday Target | 100.87 |
| Downside Intraday Target | 98.13 |
| Upside Intraday Target | 106.6 |
| Upside Intraday Target | 109.59 |
| Upside Intraday Target | 103.86 |
Weekly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 22 Thu Aug 2024 | 103.62 | 102.00 | 106.84 | 101.11 | 0.5 times |
| 16 Fri Aug 2024 | 102.21 | 103.28 | 106.75 | 98.71 | 0.919 times |
| 09 Fri Aug 2024 | 100.15 | 90.29 | 102.04 | 90.29 | 1.034 times |
| 02 Fri Aug 2024 | 100.19 | 107.29 | 112.13 | 98.94 | 1.264 times |
| 26 Fri Jul 2024 | 107.14 | 100.33 | 108.91 | 98.03 | 0.895 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 22 Thu Aug 2024 | 103.62 | 108.42 | 108.98 | 90.29 | 0.615 times |
| 31 Wed Jul 2024 | 108.99 | 83.76 | 112.13 | 81.74 | 1.331 times |
| 28 Fri Jun 2024 | 84.26 | 85.44 | 88.73 | 77.43 | 0.732 times |
| 31 Fri May 2024 | 85.05 | 70.12 | 88.52 | 69.51 | 0.924 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ligand Pharmaceuticals (LGND)
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 102.6 and Ligand Pharmaceuticals (LGND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 102.6 and Ligand Pharmaceuticals (LGND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.